Literature DB >> 7574218

HIV-1 messenger RNA in peripheral blood mononuclear cells as an early marker of risk for progression to AIDS.

K Saksela1, C E Stevens, P Rubinstein, P E Taylor, D Baltimore.   

Abstract

OBJECTIVE: To establish human immunodeficiency virus type 1 (HIV-1) messenger RNA (mRNA) expression in peripheral blood mononuclear cells as a marker of risk for progression to the acquired immunodeficiency syndrome (AIDS) in a large cohort of HIV-infected persons followed for a prolonged period.
DESIGN: Retrospective testing of cryopreserved, coded specimens.
SETTING: Research laboratories at the New York Blood Center and the Rockefeller University. PATIENTS: 150 homosexual men infected with HIV-1 who did not have an AIDS diagnosis at the time of testing. MEASUREMENTS: Multiply spliced and unspliced HIV-1 mRNAs in total peripheral blood mononuclear cell RNA were quantitated using reverse transcriptase-initiated polymerase chain reaction (PCR) and compared with other laboratory data and clinical outcome during the subsequent 8 years.
RESULTS: Although HIV-1 mRNA expression generally correlated with immunologic status, it was associated with future disease progression independently of CD4+ cell counts or their rate of decrease at the time of sampling. The association of HIV-1 mRNA with disease progression in persons with CD4+ cell counts higher than the median (> 624 cells/mm3) was particularly noteworthy; further variation in the CD4+ cell counts within this group was not prognostically significant.
CONCLUSIONS: The expression of HIV-1 mRNA in peripheral blood mononuclear cells is a strong independent marker for future HIV disease progression, even in persons with normal T-cell subsets.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7574218     DOI: 10.7326/0003-4819-123-9-199511010-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  20 in total

1.  High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors.

Authors:  P Gupta; J Mellors; L Kingsley; S Riddler; M K Singh; S Schreiber; M Cronin; C R Rinaldo
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Dynamics of HIV-1 mRNA expression in patients with long-term nonprogressive HIV-1 infection.

Authors:  M Comar; C Simonelli; S Zanussi; P Paoli; E Vaccher; U Tirelli; M Giacca
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

3.  Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.

Authors:  Tuofu Zhu; David Muthui; Sarah Holte; David Nickle; Feng Feng; Scott Brodie; Yon Hwangbo; James I Mullins; Lawrence Corey
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

4.  Highly sensitive methods for quantitation of human immunodeficiency virus type 1 RNA from plasma, cells, and tissues.

Authors:  M Fischer; W Huber; A Kallivroussis; P Ott; M Opravil; R Lüthy; R Weber; R W Cone
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

5.  Ultrasensitive reverse transcription-PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma.

Authors:  R Sun; J Ku; H Jayakar; J C Kuo; D Brambilla; S Herman; M Rosenstraus; J Spadoro
Journal:  J Clin Microbiol       Date:  1998-10       Impact factor: 5.948

6.  Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival.

Authors:  A Watson; J Ranchalis; B Travis; J McClure; W Sutton; P R Johnson; S L Hu; N L Haigwood
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

7.  Quantification of human immunodeficiency virus type 1 RNA from dried plasma spots collected on filter paper.

Authors:  S Cassol; M J Gill; R Pilon; M Cormier; R F Voigt; B Willoughby; J Forbes
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

8.  Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Authors:  Leondios G Kostrikis; Giota Touloumi; Rose Karanicolas; Nikos Pantazis; Cleo Anastassopoulou; Anastasia Karafoulidou; James J Goedert; Angelos Hatzakis
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Authors:  Alexander O Pasternak; Marlous L Grijsen; Ferdinand W Wit; Margreet Bakker; Suzanne Jurriaans; Jan M Prins; Ben Berkhout
Journal:  JCI Insight       Date:  2020-03-26

10.  Blood biomarkers of expressed and inducible HIV-1.

Authors:  Anthony R Cillo; Francis Hong; Angela Tsai; Alivelu Irrinki; Jasmine Kaur; Derek D Sloan; Mattie Follen; Romas Geleziunas; Tomas Cihlar; Sandra S Win; Jeffrey P Murry; John W Mellors
Journal:  AIDS       Date:  2018-03-27       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.